PROBIOTICS. USE OF THE L. RHAMNOSUS STRAIN IN NON-INFECTIOUS DISEASES OF THE GASTROINTESTINAL TRACT

  • N.M. Bogdanova Saint Petersburg State Pediatric Medical University. Lithuania 2, Saint Petersburg, Russian Federation, 194100
Keywords:
пробиотик штаммоспецифичность L. rhamnosus (LGG) функциональные гастроинте- стинальные расстройства запор колики срыгивание абдоминальная боль непереносимость лактозы воспалительные заболевания кишечника болезнь Крона неспецифический энтероколит probiotic strain-specificity L. rhamnosus (LGG) functional gastrointestinal disorders constipation colic regurgitation lactose intolerance inflammatory bowel diseases Crohn’s disease nonspecific enterocolitis

Abstract

Probiotics are living, apatogenic bacteria for humans that have antagonistic activity against pathogenic and conditionally pathogenic bacteria that ensure the restoration of normal microbiota. Not every microorganism can be assigned the status of “probiotic”, but only those that are considered safe and meet certain criteria. Despite the fact that most of the probiotics are represented by isolates of the indigenous microbiota, the mechanism of their action in human bionishes is not equivalent to endogenous microorganisms. Functional gastrointestinal disorders (FGID) are widespread among children of any age. Changes in the “passport” of the intestinal microbiome can aff ect the key mechanisms associated with the symptoms of FGIR. Very often, the causes of digestive discomfort (abdominal pain, bloating, fl atulence, fl atulence and diarrhea) are associated with lactose intolerance (NL). Infl ammatory bowel diseases (IBD) are characterized by bidirectional mutual.